Lantheus (NASDAQ:LNTH) executives on the company’s fourth-quarter and full-year 2025 earnings call outlined a sharpened strategic focus on PET radiodiagnostics, progress integrating recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results